Natixis Securities Americas

Natixis Securities Americas is the U.S.-based broker-dealer and investment banking subsidiary of Natixis, a major French corporate and investment bank. The firm serves as a strategic financial partner to the healthcare and life sciences sectors, providing services such as mergers and acquisitions (M&A) advisory, equity research, and capital raising through debt and equity markets. While not a drug developer itself, Natixis Securities Americas plays a critical role in the biotech ecosystem by facilitating the flow of capital to innovative pharmaceutical and medical technology companies. The firm leverages its global network to support mid-to-large cap healthcare companies in navigating complex financial transactions. It is a key component of Natixis's global Corporate & Investment Banking division and is ultimately owned by Groupe BPCE.